Reference
- Allis, C. D., Berger, S. L., Cote, J., Dent, S., Jenuwien, T., Kouzarides, T., … Shilatifard, A. (2007). New nomenclature for chromatin-modifying enzymes. Cell, 131, 633–636. https://doi.org/10.1016/j.cell.2007.10.039
- Bianco-Miotto, T., Chiam, K., Buchanan, G., Jindal, S., Day, T. K., Thomas, M., … Horvath, L. G. (2010). Global levels of specific histone modifications and an epigenetic gene signature predict prostate cancer progression and development. Cancer Epidemiology and Prevention Biomarkers, 19, 2611–2622. https://doi.org/10.1158/1055-9965.EPI-10-0555
- Brownell, J. E., & Allis, C. D. (1996). Special HATs for special occasions: linking histone acetylation to chromatin assembly and gene activation. Current Opinion in Genetics & Development, 6, 176–184. https://doi.org/10.1016/S0959-437X(96)80048-7
- Choudhary, C., Kumar, C., Gnad, F., Nielsen, M. L., Rehman, M., Walther, T. C., … Mann, M. (2009). Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science, 325, 834–840. https://doi.org/10.1126/science.1175371
- Duclot, F., Meffre, J., Jacquet, C., Gongora, C., & Maurice, T. (2010). Mice knock out for the histone acetyltransferase p300/CBP binding protein-associated factor develop a resistance to amyloid toxicity. Neuroscience, 167, 850–863. https://doi.org/10.1016/j.neuroscience.2010.02.055.
- Eroglu, E., & Türkmen, H. (2007). A DFT-based quantum theoretic QSAR study of aromatic and heterocyclic sulfonamides as carbonic anhydrase inhibitors against isozyme, CA-II. Journal of Molecular Graphics and Modelling, 26, 701–708. https://doi.org/10.1016/j.jmgm.2007.03.015
- Filippakopoulos, P., Picaud, S., Mangos, M., Keates, T., Lambert, J. P., Barsyte-Lovejoy, D., … Knapp, S. (2012). Histone recognition and large-scale structural analysis of the human bromodomain family. Cell, 149(1), 214–231. https://doi.org/10.1016/j.jmgm.2007.03.015
- Giles, R. H., Peters, D. J., & Breuning, M. H. (1998). Conjunction dysfunction: CBP/p300 in human disease. Trends in Genetics, 14, 178–183. https://doi.org/10.1016/S0168-9525(98)01438-3
- Guo, Z., Mohanty, U., Noehre, J., Sawyer, T. K., Sherman, W., & Krilov, G. (2010). Probing the α-helical structural stability of stapled p53 peptides: Molecular dynamics simulations and analysis. Chemical Biology & Drug Design, 75, 348–359. https://doi.org/10.1111/j.1747-0285.2010.00951.x.
- Gupta, S., Suryanarayanan, V., Yadav, S., Singh, S. K., & Saxena, J. K. (2017). Delineating the role of ionic interactions in structural and functional integrity of B. malayi Guanylate kinase. International Journal of Biological Macromolecules, 98, 357–365. https://doi.org/10.1016/j.ijbiomac.2017.01.098
- Haberland, M., Montgomery, R. L., & Olson, E. N. (2009). The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nature Reviews Genetics, 10(1), 32. https://doi.org/10.1038/nrg2485
- Heery, D. M., & Fischer, P. M. (2007). Pharmacological targeting of lysine acetyltransferases in human disease: a progress report. Drug Discovery Today, 12(1–2), 88–99. https://doi.org/10.1016/j.drudis.2006.11.012
- Jain, S. V., Sonawane, L. V., Patil, R. R., & Bari, S. B. (2012). Pharmacophore modeling of some novel indole β-diketo acid and coumarin-based derivatives as HIV integrase inhibitors. Medicinal Chemistry Research, 21, 165–173. https://doi.org/10.1007/s00044-010-9520-1
- Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W., & Klein, M. L. (1983). Comparison of simple potential functions for simulating liquid water. The Journal of Chemical Physics, 79, 926–935. https://doi.org/10.1002/prot.24694
- Kim, S. C., Sprung, R., Chen, Y., Xu, Y., Ball, H., Pei, J., … Grishin, N. V. (2006). Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. Molecular Cell, 23, 607–618. https://doi.org/10.1016/j.molcel.2006.06.026
- Kleff, S., Andrulis, E. D., Anderson, C. W., & Sternglanz, R. (1995). Identification of a gene encoding a yeast histone H4 acetyltransferase. Journal of Biological Chemistry, 270, 24674–24677. https://doi.org/10.1074/jbc.270.42.24674
- Kruidenier, L., Lee, K., Tough, D. F., & Wilson, D. M. (2014). Inhibitors of bromodomain containing protein PCAF for the treatment of autoimmune and inflammatory diseases or for the treatment of cancer. WO2014/037362A1.
- Kuo, M. H., & Allis, C. D. (1998). Roles of histone acetyltransferases and deacetylases in gene regulation. BioEssays, 20, 615–626. https://doi.org/10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H
- Lau, O. D., Courtney, A. D., Vassilev, A., Marzilli, L. A., Cotter, R. J., Nakatani, Y., & Cole, P. A. (2000a). p300/CBP-associated factor histone acetyltransferase processing of a peptide substrate. Kinetic analysis of the catalytic mechanism. Journal of Biological Chemistry, 275, 21953–21959. https://doi.org/10.1074/jbc.M003219200
- Lau, O. D., Kundu, T. K., Soccio, R. E., Ait-Si-Ali, S., Khalil, E. M., Vassilev, A., … Cole, P. A. (2000a). HATs off: selective synthetic inhibitors of the histone acetyltransferases p300 and PCAF. Molecular Cell, 5, 5, 589–595. −https://doi.org/10.1016/S109700)80452-9
- Li, J., Abel, R., Zhu, K., Cao, Y., Zhao, S., & Friesner, R. A. (2011). The VSGB 2.0 model: a next generation energy model for high resolution protein structure modeling. Proteins: Structure, Function, and Bioinformatics, 79, 2794. https://doi.org/10.1002/prot.23106.
- Linares, L. K., Kiernan, R., Triboulet, R., Chable-Bessia, C., Latreille, D., Cuvier, O., … Benkirane, M. (2007). Intrinsic ubiquitination activity of PCAF controls the stability of the oncoprotein Hdm2. Nature Cell Biology, 9, 331–338. https://doi.org/10.1038/ncb1545
- Lyne, P. D., Lamb, M. L., & Saeh, J. C. (2006). Accurate prediction of the relative potencies of members of a series of kinase inhibitors using molecular docking and MM-GBSA scoring. Journal of Medicinal Chemistry, 49, 4805–4808. https://doi.org/10.1021/jm060522a
- Malatesta, M., Steinhauer, C., Mohammad, F., Pandey, D. P., Squatrito, M., & Helin, K. (2013). Histone acetyltransferase PCAF is required for hedgehog-Gli-dependent transcription and cancer cell proliferation. Cancer Research, 73, 6323–6333. https://doi.org/10.1158/0008-5472.CAN-12-4660.
- Mark, P., & Nilsson, L. (2001). Structure and Dynamics of the TIP3P, SPC, and SPC/E Water Models at 298 K. The Journal of Physical Chemistry A, 105, 9954–9960. https://doi.org/10.1021/jp003020w
- Marmorstein, R., & Zhou, M. M. (2014). Writers and readers of histone acetylation: structure, mechanism, and inhibition. Cold Spring Harbor Perspectives in Biology, 6, a018762. https://doi.org/10.1101/cshperspect.a018762
- Masumi, A., Wang, I.-M., Lefebvre, B., Yang, X.-J., Nakatani, Y., & Ozato, K. (1999). The histone acetylase PCAF is a phorbol-ester-inducible coactivator of the IRF family that confers enhanced interferon responsiveness. Molecular and Cellular Biology, 19, 1810–1820. https://doi.org/10.1128/MCB.19.3.1810
- Milite, C., Castellano, S., Benedetti, R., Tosco, A., Ciliberti, C., Vicidomini, C., … Sbardella, G. (2011). Modulation of the activity of histone acetyltransferases by long chain alkylidenemalonates (LoCAMs). Bioorganic & Medicinal Chemistry Letters, 19, 3690–3701. https://doi.org/10.1016/j.bmc.2011.01.013
- Modak, R., Basha, J., Bharathy, N., Maity, K., Mizar, P., Bhat, A. V., … Kundu, T. K. (2013). Probing p300/CBP associated factor (PCAF)-dependent pathways with a small molecule inhibitor. ACS Chemical Biology, 8, 1311–1323. https://doi.org/10.1021/cb4000597.
- Nagy, Z., & Tora, L. (2007). Distinct GCN5/PCAF-containing complexes function as co-activators and are involved in transcription factor and global histone acetylation. Oncogene, 26, 5341. https://doi.org/10.1038/sj.onc.1210604
- Naik, P. K., Santoshi, S., & Joshi, H. C. (2012). Noscapinoids with anti-cancer activity against human acute lymphoblastic leukemia cells (CEM): a three dimensional chemical space pharmacophore modeling and electronic feature analysis. Journal of Molecular Modeling, 18(1), 307–318. https://doi.org/10.1007/s00894-011-1057-9.
- Ogryzko, V. V., Schiltz, R. L., Russanova, V., Howard, B. H., & Nakatani, Y. (1996). The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell, 87, 953–959. https://doi.org/10.1016/S0092-8674(00)82001-2
- Paulino, M., Alvareda, E. M., Denis, P. A., Barreiro, E. J., Sperandio da Silva, G. M., Dubin, M., … Tapia, O. (2008). Studies of trypanocidal (inhibitory) power of naphthoquinones: evaluation of quantum chemical molecular descriptors for structure-activity relationships. European Journal of Medicinal Chemistry, 43, 2238–2246. https://doi.org/10.1016/j.ejmech.2007.12.023
- Rajendrasozhan, S., Yao, H., & Rahman, I. (2009). Current perspectives on role of chromatin modifications and deacetylases in lung inflammation in COPD. Copd, 6, 291–297. https://doi.org/10.1080/15412550903049132
- Sbardella, G., Castellano, S., Vicidomini, C., Rotili, D., Nebbioso, A., Miceli, M., … Mai, A. (2008). Identification of long chain alkylidenemalonates as novel small molecule modulators of histone acetyltransferases. Bioorganic & Medicinal Chemistry Letters, 18, 2788–2792. https://doi.org/10.1016/j.bmcl.2008.04.017
- Sheikh, B. N. (2014). Crafting the brain–role of histone acetyltransferases in neural development and disease. Cell and Tissue Research, 356, 553–573. https://doi.org/10.1007/s00441-014-1835-7
- Sirin, S., Pearlman, D. A., & Sherman, W. (2014). Physics-based enzyme design: predicting binding affinity and catalytic activity. Proteins: Structure, Function, and Bioinformatics, 82, 3397–3409. https://doi.org/10.1002/prot.24694
- Sivanandam, M., Saravanan, K., & Kumaradhas, P. (2017). Insights into intermolecular interactions, electrostatic properties and the stability of C646 in the binding pocket of p300 histone acetyltransferase enzyme: a combined molecular dynamics and charge density study. Journal of Biomolecular Structure and Dynamics, 1–19. https://doi.org/10.1080/07391102.2017.1384761
- Sixto-López, Y., Bello, M., Rodríguez-Fonseca, R. A., Rosales-Hernández, M. C., Martínez-Archundia, M., Gómez-Vidal, J. A., & Correa-Basurto, J. (2017). Searching the conformational complexity and binding properties of HDAC6 through docking and molecular dynamic simulations. Journal of Biomolecular Structure and Dynamics, 35, 2794–2814. https://doi.org/10.1080/07391102.2016.1231084
- Spange, S., Wagner, T., Heinzel, T., & Krämer, O. H. (2009). Acetylation of non-histone proteins modulates cellular signalling at multiple levels. The International Journal of Biochemistry & Cell Biology, 41(1), 185–198. https://doi.org/10.1016/j.biocel.2008.08.027
- Stiehl, D. P., Fath, D. M., Liang, D., Jiang, Y., & Sang, N. (2007). Histone deacetylase inhibitors synergize p300 autoacetylation that regulates its transactivation activity and complex formation. Cancer Research, 67, 2256–2264. https://doi.org/10.1158/0008-5472.CAN-06-3985.
- Stimson, L., Rowlands, M. G., Newbatt, Y. M., Smith, N. F., Raynaud, F. I., Rogers, P., … Aherne, G. W. (2005). Isothiazolones as inhibitors of PCAF and p300 histone acetyltransferase activity. Molecular Cancer Therapeutics, 4, 1521–1532. https://doi.org/10.1158/1535-7163.MCT-05-0135
- Sun, Y., Jiang, X., Chen, S., & Price, B. D. (2006). Inhibition of histone acetyltransferase activity by anacardic acid sensitizes tumor cells to ionizing radiation. FEBS Letters, 580, 4353–4356. https://doi.org/10.1016/j.febslet.2006.06.092
- Suryanarayanan, V., & Singh, S. K. (2018). Unravelling novel congeners from acetyllysine mimicking ligand targeting a lysine acetyltransferase PCAF bromodomain. Journal of Biomolecular Structure and Dynamics, 1–17. https://doi.org/10.1080/07391102.2017.1415820
- Suryanarayanan, V., & Singh, S. K. (2015). Assessment of dual inhibition property of newly discovered inhibitors against PCAF and GCN5 through in silico screening, molecular dynamics simulation and DFT approach. Journal of Receptors and Signal Transduction, 35, 370–380. https://doi.org/10.3109/10799893.2014.956756
- Suryanarayanan, V., Singh, S. K., Tripathi, S. K., Selvaraj, C., Reddy, K. K., & Karthiga, A. (2013). A three-dimensional chemical phase pharmacophore mapping, QSAR modelling and electronic feature analysis of benzofuran salicylic acid derivatives as LYP inhibitors. SAR and QSAR in Environmental Research, 24, 1025–1040. https://doi.org/10.1080/1062936X.2013.821421
- Tawari, N. R., & Degani, M. S. (2009). Pharmacophore mapping and electronic feature analysis for a series of nitroaromatic compounds with antitubercular activity. Journal of Computational Chemistry, NA. https://doi.org/10.1002/jcc.21371.
- Tawari, N. R., & Degani, M. S. (2011). Pharmacophore modeling and density functional theory analysis for a series of nitroimidazole compounds with antitubercular activity. Chemical Biology & Drug Design, 78, 408–417. https://doi.org/10.1111/j.1747-0285.2011.01161.x.
- Tomar, J. S., & Peddinti, R. K. (2017). A. baumannii histone acetyl transferase Hpa2: optimization of homology modeling, analysis of protein–protein interaction and virtual screening. Journal of Biomolecular Structure and Dynamics, 35, 1115–1126. https://doi.org/10.1080/07391102.2016.1172025
- Tripathi, S. K., & Singh, S. K. (2014). Insights into the structural basis of 3,5-diaminoindazoles as CDK2 inhibitors: prediction of binding modes and potency by QM-MM interaction, MESP and MD simulation. Molecular Biosystems, 10, 2189–2201. https://doi.org/10.1039/c4mb00077c
- Vidali, G., Gershey, E. L., & Allfrey, V. G. (1968). Chemical studies of histone acetylation. The distribution of epsilon-N-acetyllysine in calf thymus histones. The Journal of Biological Chemistry, 243, 6361–6366.
- Yang, X. J., Ogryzko, V. V., Nishikawa, J.-I., Howard, B. H., & Nakatani, Y. (1996). A p300/CBP associated factor that competes with the adenoviral oncoprotein E1A. Nature, 382, 319–324. https://doi.org/10.1038/382319a0
- Zeng, L., & Zhou, M. M. (2002). Bromodomain: an acetyl‐lysine binding domain. FEBS Letters, 513(1), 124–128. https://doi.org/10.1016/S0014-5793(01)03309-9